Morbidity and mortality in obstructive sleep apnea syndrome 2: Effect of treatment on neuropsychiatric morbidity and quality of life
Version of Record online: 10 JUN 2003
Sleep and Biological Rhythms
Volume 1, Issue 2, pages 65–74, June 2003
How to Cite
AL-BARRAK, M., SHEPERTYCKY, M. R. and KRYGER, M. H. (2003), Morbidity and mortality in obstructive sleep apnea syndrome 2: Effect of treatment on neuropsychiatric morbidity and quality of life. Sleep and Biological Rhythms, 1: 65–74. doi: 10.1046/j.1446-9235.2003.00008.x
- Issue online: 10 JUN 2003
- Version of Record online: 10 JUN 2003
- Accepted for publication 8 November 2002.
- automobile accidents;
- quality of life;
Episodes of breathing cessation in patients with obstructive sleep apnea syndrome (OSAS) result in repetitive nocturnal oxygen desaturation, electroencephalographic arousals, and fragmentation of sleep. As a result of these changes, patients have both cardiovascular and neuropsychiatric sequelae. The most common presentations of OSAS patients are related to sleepiness and its consequences. In this review, we examine the link between OSAS and neuropsychiatric problems, and quality of life. Reports have linked OSAS to a variety of neuropsychiatric problems (psychiatric disorders, impaired cognitive function, impaired performance), poor quality of life, and an increased automobile accident rate. Treatment, usually with continuous positive airway pressure (CPAP), has been shown to improve many of the neuropsychiatric abnormalities and quality-of-life issues, however, some residual abnormalities may persist.